Drugs / Measles, Mumps and Rubella vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00262002 Background | Sep 2004 → Jul 2005 | meningococcemia | Novartis Vaccines | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles, Mumps and Rubella vaccine | “MMR (Measles, Mumps and Rubella vaccine)” NCT00262002 ↗ |
| Known as | MMR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00262002 ↗ |
| Modality | Vaccine | “MMR (Measles, Mumps and Rubella vaccine)” NCT00262002 ↗ |